Related Experiment Videos
High-density lipoprotein cholesterol and liver disease
Hepatology (Baltimore, Md.)
|May 1, 1983
Summary
High-density lipoprotein cholesterol (HDLC) levels significantly decrease in patients with various forms of liver disease, including hepatitis and cancer. This finding highlights HDLC as a potential biomarker for liver health.
Area of Science:
- Hepatology
- Clinical Chemistry
- Biomarkers
Background:
- High-density lipoprotein cholesterol (HDLC) is a key lipid parameter.
- The relationship between HDLC and liver disease requires further elucidation.
Purpose of the Study:
- To investigate the association between HDLC concentrations and biopsy-proven liver disease.
- To assess HDLC levels across different liver conditions.
Main Methods:
- 169 patients underwent liver biopsy, serum cholesterol, and HDLC evaluation.
- Serial testing of cholesterol, HDLC, prothrombin, and aminotransferase levels in 24 patients.
Main Results:
- HDLC significantly decreased in acute alcoholic hepatitis, acute viral hepatitis, inactive alcoholic liver disease, chronic active hepatitis, and hepatic neoplasms.
- A strong direct correlation was observed between HDLC and prothrombin activity (r=0.71–0.98).
- Alcohol intake's positive correlation with HDLC is reversed in the presence of liver disease.
Conclusions:
- Reduced HDLC is a significant indicator across diverse liver diseases.
- HDLC serves as a potential biomarker for liver dysfunction and correlates with coagulation status.